Avid Radiopharmaceuticals' Seed Round

Avid Radiopharmaceuticals raised a round of funding on January 14, 2005. Investors include BioAdvance.

Avid is a clinical-stage product-focused molecular imaging company with IP in the field of molecular brain imaging. Per the company, Avid has developed targeting agents to image amyloid plaques and a…

Articles about Avid Radiopharmaceuticals' Seed Round: